Proposed Data Collections Submitted for Public Comment and Recommendations, 53428-53430 [2014-21379]
Download as PDF
53428
Federal Register / Vol. 79, No. 174 / Tuesday, September 9, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hrs.)
Type of respondents
Form name
State Education Agency .........
Exemplary Sexual Health Education Measures .....................
Sexual Health Services Measures .........................................
Safe and Supportive Environments Measures ......................
Exemplary Sexual Health Education Measures .....................
Sexual Health Services Measures .........................................
Safe and Supportive Environments Measures ......................
Exemplary Sexual Health Education Measures .....................
19
19
19
17
17
17
2
2
2
2
2
2
2
2
4
3
1
6
3
6
30/60
Sexual Health Services Measures .........................................
Safe and Supportive Environments Measures ......................
2
2
2
2
30/60
30/60
Local Education Agency .........
Non-governmental organization.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–21377 Filed 9–8–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–14–14AVQ]
tkelley on DSK3SPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
The Centers for Disease Control and
Prevention (CDC), as part of its
continuing effort to reduce public
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. To
request more information on the below
proposed project or to obtain a copy of
the information collection plan and
instruments, call 404–639–7570 or send
comments to Leroy A. Richardson, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an email to omb@cdc.gov.
Comments submitted in response to
this notice will be summarized and/or
included in the request for Office of
Management and Budget (OMB)
approval. Comments are invited on: (a)
Whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
VerDate Mar<15>2010
17:39 Sep 08, 2014
Jkt 232001
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. Written comments should
be received within 60 days of this
notice.
Proposed Project
Returning Our Veterans to
Employment and Reintegration
(ROVER): Work Stress and Assistance
Animals—New—National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Veterans with chronic posttraumatic
stress disorder (PTSD) face barriers that
prevent many of them from successfully
reintegrating into society and returning
to the work force. Various reports claim
that higher unemployment rates and
increased healthcare costs and
utilization are associated with PTSD.
Symptoms associated with PTSD
include diminished interest or
participation in significant activities,
feelings of detachment or estrangement
from others, difficulty falling or staying
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
asleep, hyper vigilance, exaggerated
startle response, difficulty with
concentration or attention, and a
restricted range of affect. Amelioration
of PTSD symptoms is necessary to
facilitate reintegration of veterans into
society and the workforce; these benefits
may also contribute positively to
veterans’ overall physical and
psychological health.
A review of mostly anecdotal
evidence suggests that animal-assisted
interventions may have general
therapeutic benefits for individuals with
PTSD. Although a few reports tout the
benefits of human-animal
companionship, no studies have
focused specifically on investigating the
elements of human-animal interactions
that might be therapeutic for individuals
with PTSD or other stress-related
disorders. Furthermore, there is scant
evidence supporting the notion that
service dogs or therapy dogs may
directly improve functioning and,
thereby, ease an individual’s
reintegration into society and
employment.
NIOSH is seeking a 3-year approval
from OMB on a research study aimed at
understanding the benefits of humananimal interactions for the purpose of
facilitating the reintegration and
employment of veterans with PTSD. The
efficacy of using service dogs or other
types of assistance dogs to help veterans
with disabilities return to work has not
been established in well-controlled
scientific studies, and fundamental
empirical evidence is scant. As a step
toward a greater understanding, a
laboratory-based work-simulation study
will be conducted to investigate the
influence of the presence of and
interactions with a dog on the reactivity
and performance of veterans with and
without PTSD to work-related and
startle stressors. Results of the
laboratory-based study will complement
the findings of another project (OMB
No. 09200985), which is gathering
information about veterans perceptions
E:\FR\FM\09SEN1.SGM
09SEN1
53429
Federal Register / Vol. 79, No. 174 / Tuesday, September 9, 2014 / Notices
of the barriers and facilitators to
reintegration through two national Webbased surveys. There is no duplication
of effort or burden because the research
objectives and research methods are
substantial different.
This study will be conducted at the
NIOSH research facility in Morgantown,
WV, which includes state-of-the-art
laboratories and equipment to simulate
work-related stress under controlled
conditions and will use a small-n
experimental design with multiple,
repeated assessments over time to
measure the behavioral (work
performance), psychological, and
physiological responses of participants.
The role of dogs in potentially
moderating the effects of the stressors
will be investigated with either the
absence or presence of a dog in some
conditions and a dog that is either
familiar or unfamiliar to the veteran in
other conditions. The general working
hypothesis is that the presence of, and/
or interaction with, a familiar dog
reduces stress and enhances work
performance for both veterans with and
flyers and complete the initial Webbased contact form and several prescreening forms, including the Pet
Attitude Scale, the Combat Exposure
Scale, PTSD Checklist, Medication List,
Drug Abuse Screening Test, Center for
Epidemiological Studies Depression
Scale, Short Michigan Alcoholism
Screening Tool, and the World Health
Organization Quality of Life Index Brief.
A total of 64 eligible veterans from this
pool are expected to be enrolled in the
laboratory portion of the study,
including at least 16 veterans who own
a service dog. Upon entering the study,
all enrolled veterans will complete the
Positive and Negative Affect Scale on
site, and veterans with service dogs will
complete the Big Five Inventory (BFI),
the Canine Behavioral Assessment and
Research Questionnaire (CBARQ), the
Pet Attachment and Life Impact Scale
(PALS), Dog Personality Scale (DPQ),
and the Social Style-Self and the Social
Style-Service Dog questionnaires.
There are no costs to respondents
other than their time.
without PTSD, with a greater benefit to
veterans with PTSD.
U.S. Veterans, with and without
PTSD, and veterans with service dogs
will be recruited with the assistance of
various veterans’ organizations to
participate in this research study.
During the initial recruitment phase,
veterans who receive and respond to the
recruitment announcements will
complete several Web-based
prescreening questionnaires, and
eligible veterans, who are enrolled into
the research study, will complete
additional questionnaires and tasks in
multi-day assessment sessions at the
NIOSH Morgantown facility. An
estimated 400 persons in various
veterans’ agencies will receive email
announcements of the research study
and follow-up phone calls. The work
activity associated with reading the
email, answering the phone calls, and
distributing a study announcement/flyer
to additional individuals is estimated to
take up to 10 minutes for each
occurrence. Approximately 200 veterans
are expected to see the recruitment
ESTIMATED ANNUALIZED BURDEN HOURS
Number
of
respondents
Type of respondent
Form name
Representatives of veterans organizations.
Veterans ............................................
Veterans ............................................
Veterans ............................................
Veterans ............................................
Veterans
Study
Announcement
Email/Phone Contact.
Recruitment Flyer .............................
Contact Form ...................................
Pre-Screening Pet Attitude Scale ....
Pre-Screening Combat Exposure
Scale.
Pre-Screening PTSD Checklist ........
Pre-Screening Medication List .........
Pre-Screening Drug Abuse Screening Test.
Pre-Screening
Center
for
Epidemiolo-gical Studies Depression Scale.
Pre-Screening Short Michigan Alcoholism Screening Tool.
Pre-Screening World Health Organization Quality of Life Index Brief.
Positive and Negative Affect Scale
(PANAS).
PANAS .............................................
NASA Task Load Index (NASA TLX)
Average
burden per
response
(in hours)
Total
burden
hours
400
1
10/60
67
200
64
64
64
1
1
1
1
10/60
10/60
5/60
5/60
33
11
5
5
64
64
64
1
1
1
5/60
5/60
5/60
5
5
5
64
1
5/60
5
64
1
5/60
5
64
1
10/60
11
48
3
2/60
5
16
48
6
2
2/60
2/60
3
5
16
16
16
4
1
1
2/60
10/60
10/60
2
3
3
16
1
10/60
3
Enrolled Veterans with Service Dogs
Enrolled Veterans with Service Dogs
Enrolled Veterans with Service Dogs
NASA TLX ........................................
Big Five Inventory (BFI) ...................
Canine Behavioral Assessment and
Research Questionnaire (CBARQ).
Pet Attachment and Life Impact
Scale (PALS).
Dog Personality Scale (DPQ) ..........
Social Style-Self ...............................
Social Style-Service Dog .................
16
16
16
1
1
1
10/60
10/60
10/60
3
3
3
Total ...........................................
...........................................................
........................
........................
........................
190
Veterans ............................................
Veterans ............................................
Veterans ............................................
Veterans ............................................
Veterans ............................................
Veterans ............................................
Enrolled
Dogs.
Enrolled
Enrolled
Dogs.
Enrolled
Enrolled
Enrolled
Veterans without Service
Veterans with Service Dogs
Veterans without Service
Veterans with Service Dogs
Veterans with Service Dogs
Veterans with Service Dogs
Enrolled Veterans with Service Dogs
tkelley on DSK3SPTVN1PROD with NOTICES
Number of
responses per
respondent
VerDate Mar<15>2010
17:39 Sep 08, 2014
Jkt 232001
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
E:\FR\FM\09SEN1.SGM
09SEN1
53430
Federal Register / Vol. 79, No. 174 / Tuesday, September 9, 2014 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2014–21379 Filed 9–8–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Georgia Tuberculosis Outbreak Among
Homeless
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice of award.
The Centers for Disease
Control and Prevention (CDC) located
within the United States Department of
Health and Human Services (HHS)
announces a notice of award to the
Georgia Department of Public Health,
Tuberculosis (TB) Program. This award
will be in the amount of $419,095.00.
The purpose of this award is to halt
the further spread of a drug-resistant
strain of tuberculosis associated with
multiple homeless shelters in Fulton
County, Georgia.
SUMMARY:
It is expected the notice of award
will begin on or about September 3,
2014. The project period will be for one
year.
FOR FURTHER INFORMATION CONTACT: Gail
Burns-Grant, Division of Tuberculosis
Elimination, Field Services and
Evaluation Branch, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE., MS E–10, Atlanta, GA 30333;
phone: 404–639–5344; email: GAB2@
cdc.gov.
SUPPLEMENTARY INFORMATION: Currently,
the state of Georgia is experiencing a
public health emergency in Fulton
County where there has been extensive
transmission of a drug-resistant strain of
tuberculosis (TB) associated with
multiple homeless shelters in the
county. The Georgia Department of
Public Health asked CDC to provide
emergency funding for the immediate
implementation of CDC
recommendations provided as a result
of a May 2014 outbreak investigation to
prevent further transmission of this
drug-resistant strain of tuberculosis and
to prevent further deaths associated
with this outbreak. Project number is
CDC–RFA–PS14–1416.
DATES:
Dated: September 4, 2014.
Ron A. Otten,
Acting Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2014–21455 Filed 9–4–14; 4:15 pm]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0001]
Advisory Committee Renewals;
Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice entitled ‘‘Advisory Committee
Renewals’’ that appeared in the Federal
Register of August 25, 2014 (79 FR
50658). The document announced the
renewal of certain FDA advisory
committees by the Commissioner of
Food and Drugs. The table in the
document contained several errors. This
document corrects those errors.
SUMMARY:
Lisa
Granger, Office of Policy, Food and Drug
Administration, 10903 New Hampshire
Ave., Bldg. 32, rm. 3330, Silver Spring,
MD 20993–0002, 301–796–9115.
FOR FURTHER INFORMATION CONTACT:
In the
Federal Register of Monday, August 25,
2014, in FR Doc. 2014–20017, on page
50659 the table is corrected to read:
SUPPLEMENTARY INFORMATION:
Name of committee
Date of expiration
Advisory Committee for Pharmaceutical Science and Clinical Pharmacology .......................................................................
Gastrointestinal Drugs Advisory Committee ............................................................................................................................
Bone, Reproductive and Urologic Drugs Advisory Committee (formerly Reproductive Health Drugs Advisory Committee)
Arthritis Advisory Committee ...................................................................................................................................................
Pharmacy Compounding Advisory Committee ........................................................................................................................
Anesthetic and Analgesic Drugs Advisory Committee ............................................................................................................
Blood Products Advisory Committee .......................................................................................................................................
Pulmonary-Allergy Drugs Advisory Committee .......................................................................................................................
Drug Safety and Risk Management Advisory Committee .......................................................................................................
Science Advisory Board to the National Center for Toxicological Research ..........................................................................
Peripheral and Central Nervous System Drugs Advisory Committee ....................................................................................
Psychopharmacologic Drugs Advisory Committee .................................................................................................................
Transmissible and Spongiform Encephalopathies Advisory Committee .................................................................................
Science Board to the Food and Drug Administration .............................................................................................................
Allergenic Products Advisory Committee ................................................................................................................................
Dated: September 3, 2014.
Jill Hartzler Warner,
Associate Commissioner for Special Medical
Programs.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
[Docket No. FDA–2014–N–1049]
Exploring the Expansion of
Conditional Approval to Appropriate
Categories of New Animal Drugs
AGENCY:
Food and Drug Administration,
HHS.
VerDate Mar<15>2010
17:39 Sep 08, 2014
Jkt 232001
Notice.
The Food and Drug
Administration (FDA) is announcing
that it is beginning the exploration
process described in a stated
performance goal in the Animal Drug
User Fee Amendments of 2013 (ADUFA
III) goals letter. Consistent with the
performance goal, the FDA is inviting
comments in regard to the Agency
exploring the use of statutory changes to
expand the use of conditional approval
SUMMARY:
Food and Drug Administration
[FR Doc. 2014–21369 Filed 9–8–14; 8:45 am]
BILLING CODE 4164–01–P
ACTION:
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
January 22, 2016.
March 3, 2016.
March 23, 2016.
April 5, 2016.
April 25, 2016.
May 1, 2016.
May 13, 2016.
May 30, 2016.
May 31, 2016.
June 2, 2016.
June 4, 2016.
June 4, 2016.
June 9, 2016.
June 26, 2016.
July 9, 2016.
E:\FR\FM\09SEN1.SGM
09SEN1
Agencies
[Federal Register Volume 79, Number 174 (Tuesday, September 9, 2014)]
[Notices]
[Pages 53428-53430]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21379]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-14-14AVQ]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC), as part of
its continuing effort to reduce public burden, invites the general
public and other Federal agencies to take this opportunity to comment
on proposed and/or continuing information collections, as required by
the Paperwork Reduction Act of 1995. To request more information on the
below proposed project or to obtain a copy of the information
collection plan and instruments, call 404-639-7570 or send comments to
Leroy A. Richardson, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments submitted in response to this notice will be summarized
and/or included in the request for Office of Management and Budget
(OMB) approval. Comments are invited on: (a) Whether the proposed
collection of information is necessary for the proper performance of
the functions of the agency, including whether the information shall
have practical utility; (b) the accuracy of the agency's estimate of
the burden of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology; and (e)
estimates of capital or start-up costs and costs of operation,
maintenance, and purchase of services to provide information. Burden
means the total time, effort, or financial resources expended by
persons to generate, maintain, retain, disclose or provide information
to or for a Federal agency. This includes the time needed to review
instructions; to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information; to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information; and to transmit or otherwise
disclose the information. Written comments should be received within 60
days of this notice.
Proposed Project
Returning Our Veterans to Employment and Reintegration (ROVER):
Work Stress and Assistance Animals--New--National Institute for
Occupational Safety and Health (NIOSH), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Veterans with chronic posttraumatic stress disorder (PTSD) face
barriers that prevent many of them from successfully reintegrating into
society and returning to the work force. Various reports claim that
higher unemployment rates and increased healthcare costs and
utilization are associated with PTSD.
Symptoms associated with PTSD include diminished interest or
participation in significant activities, feelings of detachment or
estrangement from others, difficulty falling or staying asleep, hyper
vigilance, exaggerated startle response, difficulty with concentration
or attention, and a restricted range of affect. Amelioration of PTSD
symptoms is necessary to facilitate reintegration of veterans into
society and the workforce; these benefits may also contribute
positively to veterans' overall physical and psychological health.
A review of mostly anecdotal evidence suggests that animal-assisted
interventions may have general therapeutic benefits for individuals
with PTSD. Although a few reports tout the benefits of human-animal
companionship, no studies have focused specifically on investigating
the elements of human-animal interactions that might be therapeutic for
individuals with PTSD or other stress-related disorders. Furthermore,
there is scant evidence supporting the notion that service dogs or
therapy dogs may directly improve functioning and, thereby, ease an
individual's reintegration into society and employment.
NIOSH is seeking a 3-year approval from OMB on a research study
aimed at understanding the benefits of human-animal interactions for
the purpose of facilitating the reintegration and employment of
veterans with PTSD. The efficacy of using service dogs or other types
of assistance dogs to help veterans with disabilities return to work
has not been established in well-controlled scientific studies, and
fundamental empirical evidence is scant. As a step toward a greater
understanding, a laboratory-based work-simulation study will be
conducted to investigate the influence of the presence of and
interactions with a dog on the reactivity and performance of veterans
with and without PTSD to work-related and startle stressors. Results of
the laboratory-based study will complement the findings of another
project (OMB No. 09200985), which is gathering information about
veterans perceptions
[[Page 53429]]
of the barriers and facilitators to reintegration through two national
Web-based surveys. There is no duplication of effort or burden because
the research objectives and research methods are substantial different.
This study will be conducted at the NIOSH research facility in
Morgantown, WV, which includes state-of-the-art laboratories and
equipment to simulate work-related stress under controlled conditions
and will use a small-n experimental design with multiple, repeated
assessments over time to measure the behavioral (work performance),
psychological, and physiological responses of participants. The role of
dogs in potentially moderating the effects of the stressors will be
investigated with either the absence or presence of a dog in some
conditions and a dog that is either familiar or unfamiliar to the
veteran in other conditions. The general working hypothesis is that the
presence of, and/or interaction with, a familiar dog reduces stress and
enhances work performance for both veterans with and without PTSD, with
a greater benefit to veterans with PTSD.
U.S. Veterans, with and without PTSD, and veterans with service
dogs will be recruited with the assistance of various veterans'
organizations to participate in this research study. During the initial
recruitment phase, veterans who receive and respond to the recruitment
announcements will complete several Web-based prescreening
questionnaires, and eligible veterans, who are enrolled into the
research study, will complete additional questionnaires and tasks in
multi-day assessment sessions at the NIOSH Morgantown facility. An
estimated 400 persons in various veterans' agencies will receive email
announcements of the research study and follow-up phone calls. The work
activity associated with reading the email, answering the phone calls,
and distributing a study announcement/flyer to additional individuals
is estimated to take up to 10 minutes for each occurrence.
Approximately 200 veterans are expected to see the recruitment flyers
and complete the initial Web-based contact form and several pre-
screening forms, including the Pet Attitude Scale, the Combat Exposure
Scale, PTSD Checklist, Medication List, Drug Abuse Screening Test,
Center for Epidemiological Studies Depression Scale, Short Michigan
Alcoholism Screening Tool, and the World Health Organization Quality of
Life Index Brief. A total of 64 eligible veterans from this pool are
expected to be enrolled in the laboratory portion of the study,
including at least 16 veterans who own a service dog. Upon entering the
study, all enrolled veterans will complete the Positive and Negative
Affect Scale on site, and veterans with service dogs will complete the
Big Five Inventory (BFI), the Canine Behavioral Assessment and Research
Questionnaire (CBARQ), the Pet Attachment and Life Impact Scale (PALS),
Dog Personality Scale (DPQ), and the Social Style-Self and the Social
Style-Service Dog questionnaires.
There are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Representatives of veterans Veterans Study 400 1 10/60 67
organizations. Announcement
Email/Phone
Contact.
Veterans...................... Recruitment 200 1 10/60 33
Flyer.
Veterans...................... Contact Form.... 64 1 10/60 11
Veterans...................... Pre-Screening 64 1 5/60 5
Pet Attitude
Scale.
Veterans...................... Pre-Screening 64 1 5/60 5
Combat Exposure
Scale.
Veterans...................... Pre-Screening 64 1 5/60 5
PTSD Checklist.
Veterans...................... Pre-Screening 64 1 5/60 5
Medication List.
Veterans...................... Pre-Screening 64 1 5/60 5
Drug Abuse
Screening Test.
Veterans...................... Pre-Screening 64 1 5/60 5
Center for
Epidemiolo-
gical Studies
Depression
Scale.
Veterans...................... Pre-Screening 64 1 5/60 5
Short Michigan
Alcoholism
Screening Tool.
Veterans...................... Pre-Screening 64 1 10/60 11
World Health
Organization
Quality of Life
Index Brief.
Enrolled Veterans without Positive and 48 3 2/60 5
Service Dogs. Negative Affect
Scale (PANAS).
Enrolled Veterans with Service PANAS........... 16 6 2/60 3
Dogs.
Enrolled Veterans without NASA Task Load 48 2 2/60 5
Service Dogs. Index (NASA
TLX).
Enrolled Veterans with Service NASA TLX........ 16 4 2/60 2
Dogs.
Enrolled Veterans with Service Big Five 16 1 10/60 3
Dogs. Inventory (BFI).
Enrolled Veterans with Service Canine 16 1 10/60 3
Dogs. Behavioral
Assessment and
Research
Questionnaire
(CBARQ).
Enrolled Veterans with Service Pet Attachment 16 1 10/60 3
Dogs. and Life Impact
Scale (PALS).
Enrolled Veterans with Service Dog Personality 16 1 10/60 3
Dogs. Scale (DPQ).
Enrolled Veterans with Service Social Style- 16 1 10/60 3
Dogs. Self.
Enrolled Veterans with Service Social Style- 16 1 10/60 3
Dogs. Service Dog.
rrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr ---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 190
----------------------------------------------------------------------------------------------------------------
[[Page 53430]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-21379 Filed 9-8-14; 8:45 am]
BILLING CODE 4163-18-P